Injectable Drug Delivery – Devices Focus75

Issue No #75 May 8th, 2017

Inside the magazine

SAFEGUARDING USER NEEDS: THE LONG-TERM LEGACY OF SHL’S PATIENT-CENTRIC DESIGNS

SAFEGUARDING USER NEEDS: THE LONG-TERM LEGACY OF SHL’S PATIENT-CENTRIC DESIGNS

Jochen Ratjen talks about his personal experiences, what patient-centricity means to SHL, and how SHL’s designs are moving ahead with the changing trends.

FAST-TO-MARKET LARGE VOLUME INJECTOR FOR SELF-ADMINISTRATION

Bjørn Knud Andersen

FAST-TO-MARKET LARGE VOLUME INJECTOR FOR SELF-ADMINISTRATION

In response to a set of very specific device objectives Bjørn Knud Andersen and Bjarne Sørensen present an electronic, connected large-volume injector concept for self-administration as the ideal solution.

CONTINUOUS GROWTH & INNOVATION IN COMBINATION PRODUCT MARKET PRESENTS CHALLENGES & OPPORTUNITIES

PREFILLED SYRINGES

CONTINUOUS GROWTH & INNOVATION IN COMBINATION PRODUCT MARKET PRESENTS CHALLENGES & OPPORTUNITIES

Paul Sullivan describes how smart, error-detecting training devices that are true to the form and function of the actual device deliver the most promising impact on adherence and compliance for patient self-injection.

NEEDLE-FREE JET INJECTION IN WORKPLACE INFLUENZA CLINICS

NEEDLE-FREE JET INJECTION IN WORKPLACE INFLUENZA CLINICS

Tara Miller, Chris Galloway, and William E Gannon Jr evaluate an unmet need for increasing immunisation coverage in workplace influenza clinics by offering needle-free injection technology.

READY-TO-USE COMPONENTS

READY-TO-USE COMPONENTS

Joël Cotten discusses the importance of sterile transfer in parenteral combination product manufacturing and Aptar Pharma’s gamma sterilisation suitable ready-to-use delivery device components.

INJECTABLE DRUG DELIVERY: DEVICES MEET NEXT-GENERATION FORMULATIONS

Dr Iulia Karlsson

INJECTABLE DRUG DELIVERY: DEVICES MEET NEXT-GENERATION FORMULATIONS

Iulia Karlsson, discusses a new technology called BeloGal which allows drugs to be delivered in high doses to the right organ and avoids the problems of low water solubility that hamper many modern formulations.

YPSODOSE WEARABLE DEVICE FOR THE LARGE-VOLUME INJECTION OF BIOLOGICS

YPSODOSE WEARABLE DEVICE FOR THE LARGE-VOLUME INJECTION OF BIOLOGICS

Ian Thompson describes self-injection device trends for larger injection volumes and introduces YpsoDose, a new prefilled large-volume wearable injector being developed by Ypsomed Delivery Systems.

ADJUSTING & CONTROLLING INJECTION SPEED BY DESIGN: IMPACT ON PAIN PERCEPTION

PREFILLED SYRINGES

Isabelle Delcroix

ADJUSTING & CONTROLLING INJECTION SPEED BY DESIGN: IMPACT ON PAIN PERCEPTION

Isabell Delcroix and Pascal Dugand describe a study of the multi-award-winning Safelia^® auto-injector platform, which showed how varying and slowing injection speed could reduce pain perception.

TONY BRATT, NORDIC PHARMA

TONY BRATT, NORDIC PHARMA

Tony Bratt discusses Nordic Pharma’s specialised market focused business model and how he believes drug delivery systems, in particular the platform device concept, can play an important role in this niche product field.

AUTO-INJECTOR DESIGN: MANAGING DRUG TEMPERATURE VARIATIONS

Jake Cowperthwaite

AUTO-INJECTOR DESIGN: MANAGING DRUG TEMPERATURE VARIATIONS

Jake Cowperthwaite examines the impact of environmental and drug temperature variation on auto-injector performance and describes techniques for managing this variation on modern auto-injectors.

BUILDING BRIDGES FROM DRUGS TO PATIENTS: USABILITY & HUMAN FACTORS

Sensile Medical

BUILDING BRIDGES FROM DRUGS TO PATIENTS: USABILITY & HUMAN FACTORS

Nicolas Sandoz describes Sensile Medical’s approach to ensuring it takes usability and human factors into account during the development of its devices, in particular for subcutaneous delivery.

DRUG CONTAINMENT & DELIVERY INNOVATION

West Pharmaceutical Services

DRUG CONTAINMENT & DELIVERY INNOVATION

Chris Henshall discusses how West's SmartDose platform considers the interface between drug, device and patient and how it offers an easy-to-use, reliable and integrated system for managing self-injection.

Top

W3 Total Cache is currently running in Pro version Development mode.